Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

The following is a summary of “Underutilized treatments for patients with refractory cancer pain: A qualitative study assessing the use of intrathecal drug delivery devices in the United Kingdom ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

Accurate pain reporting in sickle cell disease is critical to effective pain assessment and management, but accuracy depends on patient comprehension of forms.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

This study was approved by the Human Research Protection Office and Institutional Review Board of the Medical College of Wisconsin and Froedtert Hospital (WI, USA). Written informed consent was ...

Abdominal pain is considered chronic if it lasts for more than three months. The pain may be constant or it can come and go over the three-month period or longer. There are many health conditions, ...